Skip to Content

MYLAN 2047 MYLAN 2047 (Tacrolimus 5 mg)

Pill imprint MYLAN 2047 MYLAN 2047 has been identified as Tacrolimus 5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tacrolimus 5 mg MYLAN 2047 MYLAN 2047
Tacrolimus 5 mg MYLAN 2047 MYLAN 2047
Discount Card Promo
MYLAN 2047 MYLAN 2047
5 mg
Gray & Red
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
D&C Red No. 28
D&C Yellow No. 10
D&C Red No. 33
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0028 UDL Laboratories Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.